Virtue Capital Management, LLC Abbott Laboratories Transaction History

Virtue Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $3,827 - $4,272	-38 Reduced 1.83%	2,040 $211,000
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $99,553 - $109,952	-909 Reduced 30.43%	2,078 $236,000
Q4 2023 Feb 15, 2024	SELL	$90.19 - $110.4 $56,729 - $69,441	-629 Reduced 17.39%	2,987 $328,000
Q2 2023 Jul 18, 2023	SELL	$100.78 - $112.29 $37,590 - $41,884	-373 Reduced 9.35%	3,616 $394,000
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $63,637 - $74,904	-657 Reduced 14.14%	3,989 $403,000
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $441,648 - $518,121	4,646 New	4,646 $510,000
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $2,130 - $2,350	-37 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $2,081 - $2,353	37 New	37 $2,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Virtue Capital Management, LLC with notifications on news.